Grufity logoGrufity logo
StocksFundsSearch FilingsAPI

Allscripts Healthcare Solutions Inc Stock Research

MDRX

12.48USD-0.09(-0.72%)Market Closedas of 22 Sep 2023, 09:44 am
Watchlist

Market Summary

USD12.48-0.09
Market Closedas of 22 Sep 2023, 09:44 am
-0.72%

MDRX Stock Price

MDRX RSI Chart

MDRX Valuation

Market Cap

1.4B

Price/Earnings (Trailing)

22.47

Price/Sales (Trailing)

1.63

EV/EBITDA

2.9

Price/Free Cashflow

8.81

MDRX Price/Sales (Trailing)

MDRX Profitability

Free Cashflow Yield

11.35%

MDRX Fundamentals

MDRX Revenue

MDRX Earnings

Price Action

52 Week Range

11.3019.77
(Low)(High)

Last 7 days

0.8%

Last 30 days

-2.5%

Last 90 days

10.7%

Trailing 12 Months

-24.1%

MDRX Financial Health

MDRX Investor Care

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales

Latest Insider Trading transactions for MDRX

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-09-03
Vakharia Tejal
sold (taxes)
-16,535
13.52
-1,223
svp general counsel
2023-08-04
Poulton Richard J.
acquired
-
-
366,302
ceo
2023-08-04
Poulton Richard J.
back to issuer
-2,190,660
13.5
-162,271
ceo
2023-05-25
Hammond Lisa
sold (taxes)
-18,060
11.89
-1,519
svp & chief hr officer
2023-05-10
Poulton Richard J.
sold (taxes)
-157,140
11.9
-13,205
ceo
2023-05-10
Hammond Lisa
sold (taxes)
-28,000
11.9
-2,353
svp & chief hr officer
2023-05-10
Vakharia Tejal
sold (taxes)
-37,711
11.9
-3,169
svp general counsel
2023-05-02
Langan Thomas
sold (taxes)
-22,999
12.15
-1,893
president and cco
2023-05-02
Jones Leah
sold (taxes)
-27,009
12.15
-2,223
chief financial officer
2023-05-01
Jones Leah
sold (taxes)
-86,031
12.53
-6,866
chief financial officer

1–10 of 50

Which funds bought or sold MDRX recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-08-22
VIRGINIA RETIREMENT SYSTEMS ET AL
reduced
-40.42
-451,170
611,100
0.01%
2023-08-21
OSAIC HOLDINGS, INC.
added
72.39
34,506
86,108
-%
2023-08-21
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
added
5.72
10,000
454,000
-%
2023-08-21
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
reduced
-2.96
-111,999
1,663,770
-%
2023-08-16
Nuveen Asset Management, LLC
reduced
-34.67
-6,387,720
10,911,300
-%
2023-08-15
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO
added
0.51
-47,000
1,554,000
0.01%
2023-08-15
ALLIANCEBERNSTEIN L.P.
added
0.31
-69,961
2,150,000
-%
2023-08-15
WELLS FARGO & COMPANY/MN
added
6.22
187,585
7,528,910
-%
2023-08-15
CAPTRUST FINANCIAL ADVISORS
reduced
-9.91
-28,714
191,948
-%
2023-08-15
Belpointe Asset Management LLC
sold off
-100
-10,610
-
-%

1–10 of 44

Latest Funds Activity

Are funds buying MDRX calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own MDRX
No. of Funds

Schedule 13G FIlings of Allscripts Healthcare Solutions

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 10, 2023
dimensional fund advisors lp
8.5%
9,277,320
SC 13G/A
Feb 09, 2023
vanguard group inc
12.40%
13,550,569
SC 13G/A
Jan 26, 2023
blackrock inc.
19.1%
20,902,942
SC 13G/A
Jan 20, 2023
blackrock inc.
19.1%
20,902,942
SC 13G/A
Feb 09, 2022
vanguard group inc
10.82%
13,268,135
SC 13G/A
Feb 08, 2022
dimensional fund advisors lp
8.2%
10,090,569
SC 13G/A
Jan 28, 2022
blackrock inc.
19.5%
23,846,502
SC 13G/A
Apr 12, 2021
wellington management group llp
3.78%
5,292,953
SC 13G/A
Feb 12, 2021
dimensional fund advisors lp
6.9%
10,939,535
SC 13G/A
Feb 10, 2021
vanguard group inc
10.11%
15,973,325
SC 13G/A

Recent SEC filings of Allscripts Healthcare Solutions

View All Filings
Date Filed Form Type Document
Sep 18, 2023
8-K
Current Report
Sep 05, 2023
4
Insider Trading
Aug 18, 2023
8-K
Current Report
Aug 10, 2023
NT 10-Q
NT 10-Q
Aug 08, 2023
4
Insider Trading
Jun 14, 2023
8-K
Current Report

Peers (Alternatives to Allscripts Healthcare Solutions)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
464.6B
348.5B
1.79% -1.49%
22.01
1.33
13.69% 15.63%
32.5B
2.2B
8.51% 21.82%
60.14
14.55
11.56% 37.20%
MID-CAP
3.2B
2.5B
-15.42% -33.04%
-0.79
1.26
13.30% 59.30%
2.3B
1.2B
-11.37% -43.78%
-99.56
1.87
-1.77% -138.27%
SMALL-CAP
1.6B
678.1M
44.50% 39.22%
673.28
2.34
12.34% 2970.73%
1.4B
-
-2.48% -24.09%
22.47
1.63
- -
968.3M
319.4M
-31.51% -31.01%
-6.35
3.03
30.27% 15.64%
865.4M
2.4B
-1.69% -15.70%
6.96
0.36
-5.09% -42.39%
797.7M
55.7M
-11.73% -21.76%
76.79
14.33
7.05% -12.17%
657.9M
274.0M
1.13% -2.46%
51.11
2.4
5.60% 81.56%
559.2M
284.6M
-15.76% -1.49%
-3.8
1.96
7.33% -1.68%
215.3M
336.9M
-12.06% -46.54%
43.71
0.64
10.57% -74.53%

Allscripts Healthcare Solutions News

Mundurowe Wiadomości
Veradigm Inc. - Wpływ na NASDAQ i perspektywy inwestycyjne.
Mundurowe Wiadomości,
8 hours ago
InvestorsObserver
Clayton County Register
Business Insider
Business Insider
Business Wire
한국경제
올스크립트(MDRX) 수시 보고.
한국경제,
8 months ago
Behavioral Health Business
Business Wire

Returns for MDRX

Cumulative Returns on MDRX

-1.6%


10-Year Cumulative Returns

-0.9%


7-Year Cumulative Returns

-2.6%


5-Year Cumulative Returns

16.6%


3-Year Cumulative Returns

Risks for MDRX

What is the probability of a big loss on MDRX?

91.5%


Probability that Allscripts Healthcare Solutions stock will be more than 20% underwater in next one year

64.6%


Probability that Allscripts Healthcare Solutions stock will be more than 30% underwater in next one year.

27.3%


Probability that Allscripts Healthcare Solutions stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does MDRX drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Allscripts Healthcare Solutions was unfortunately bought at previous high price.

Drawdowns

Financials for Allscripts Healthcare Solutions

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Last 12 Months)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q22018Q12017Q42017Q3
Revenue0.9%8378308208118061,0271,2551,5031,5311,5731,6151,6331,6611,6851,7151,7501,7441,6801,5881,4981,487
Cost Of Revenue-0.7%8748818828834445997589379731,0031,0231,0221,0151,0101,0261,0251,031983915865844
Gross Profit2.2%655641630620362427497566557571592610646675690725713697673633643
  S&GA Expenses1.4%360355323314181248329390404407398401393405427451474460428401393
  R&D Expenses1.3%201198196194117142167206212227242245251253266268271254222202182
EBITDA-0.4%30030116420212.00-26.62-30.78-61.81-17.17-10.81-143-116-100--------
EBITDA Margin-1.2%0.36*0.36*0.16*0.16*0.01*-0.02*-0.02*-0.04*-0.01*-0.01*-0.08*-0.07*-0.06*--------
Interest Expenses-21.4%9.0011.0012.0013.0016.0019.0027.0034.0039.0044.0044.0043.0045.0048.0049.0051.0049.0045.0041.0038.0051.00
Earnings Before Taxes-2.1%122125160162-11.57-57.10-106-149-138-145-294-281-258-24614.0013.0021.0022.00-209-190-169
EBT Margin2.1%0.15*0.14*0.15*0.13*-0.02*-0.05*-0.05*-0.08*-0.06*-0.06*-0.14*-0.12*-0.12*--------
Net Income-2.7%61.0062.00148134775759730700-46.39-52.65-194-18222220442840837.0043.00-174-154-166
Net Income Margin-3.5%0.07*0.08*0.14*0.11*0.61*0.59*0.47*0.43*-0.03*-0.03*-0.11*-0.10*0.13*--------
Free Cashflow-14.9%155182-16.16-80.72-332-337-114-12373.0055.0022.0030.002.00--------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q22018Q12017Q42017Q3
Assets-1.4%1,6911,7142,4302,4252,4842,5402,8712,9183,1463,1893,2533,2063,2303,2353,2423,1814,5184,3544,3704,2303,883
  Current Assets-2.2%8118291,5417618058411,1351,153949870907841774804834859844856911857668
    Cash Equivalents-1.5%49350083.0013314216045453121919920413012913913717491.00114112131104
  Net PPE-21.8%12.0015.009.0010.0054.0059.0067.0072.0070.0076.0082.0088.0097.00106116122160161165135165
  Goodwill0.0%5245245205079749759759751,2871,3611,3619741,3871,3821,3749862,2081002,0511,29361.00
Liabilities-0.8%5145181,0771,0171,0661,1471,1931,2511,9381,9462,0111,9211,9491,9191,7861,6012,9332,7562,8162,6392,316
  Current Liabilities-1.3%2532566475475675968809357451,1111,1581,2111,177880800798894907889890684
    LT Debt, Current---------48.0037537136435922.0021.0020.0020.0020.0020.0028.0025.00
    LT Debt, Non Current0.2%2002003773503734211691681,0266626805515558237666481,0029831,064907747
Shareholder's Equity-1.6%1,1771,1961,3531,4081,4191,3931,6791,6661,2081,2431,2421,2851,2811,3161,4561,5801,1171,1421,1101,1601,105
  Retained Earnings2.0%75373980313.00680664642633-94.71-95.25-87.64-49.34-30.37-24.64125133-251-228-319-338-354
  Additional Paid-In Capital0.0%1,9241,9241,9221,9621,9521,9041,9071,9031,9291,9211,9151,9071,8761,8681,8581,8811,7651,7671,7711,7811,782
Shares Outstanding-1.4%109111115116123125141140158163162162163167166171175175178181181
Minority Interest----------------29.0029.0029.0038.0039.0041.00
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q22018Q12017Q42017Q3
Cashflow From Operations-14.7%161189-10.74-75.43-319-322-98.43-10684.0067.0037.0046.0020.00-0.5615.0068.00188237262279257
  Share Based Compensation1.2%46.0046.0039.0035.0017.0022.0027.0034.0035.0034.0037.0039.0038.0039.0036.0035.0034.0035.0039.0037.0036.00
Cashflow From Investing1.7%646635-37.38-12.171,6251,6211,6311,615-95.70-124-162-161351191364248-439-331-510-412-309
Cashflow From Financing2.2%-520-532-314-258-1,315-1,274-1,230-1,10997.0011419067.00-352-182-375-29226214728719985.00
  Buy Backs13.4%28625246741758963432533565.0056.0056.0011113910214613910210270.0012.0062.00

MDRX Income Statement

2022-09-30
CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Revenue:    
Revenue from contract with customers$ 151,922$ 144,668$ 445,492$ 419,526
Cost of revenue:    
Total cost of revenue68,48675,028209,093218,550
Gross profit83,43669,640236,399200,976
Selling, general and administrative expenses32,51827,392133,68387,680
Research and development23,68121,04269,85162,644
Asset impairment charges03590531
Amortization of intangible and acquisition-related assets2,2362,3636,6487,090
Income from operations25,00118,48426,21743,031
Interest expense(1,246)(3,617)(5,269)(9,709)
Other income, net1,6554,4933,80021,819
Gain on sale of businesses, net08,36308,363
Equity in net loss income of unconsolidated investments(617)(257)(1,222)(321)
Income from continuing operations before income taxes24,79327,46623,52663,183
Income tax (provision) benefit(13,868)(7,190)9,132(12,464)
Income from continuing operations, net of tax10,92520,27632,65850,719
Income (loss) from discontinued operations(434)(6,187)(9,252)(6,545)
Gain on sale of discontinued operations5,17407,939647
Income tax effect on discontinued operations(1,137)2,091(57,986)2,342
Income (loss) from discontinued operations, net of tax3,603(4,096)(59,299)(3,556)
Net income (loss)$ 14,528$ 16,180$ (26,641)$ 47,163
Basic    
Continuing operations$ 0.10$ 0.16$ 0.29$ 0.38
Discontinued operations0.03(0.03)(0.52)(0.03)
Net earnings (loss) per Common Share0.130.13(0.23)0.35
Diluted    
Continuing operations0.090.150.250.36
Discontinued operations0.03(0.03)(0.44)(0.03)
Net earnings (loss) per Common Share$ 0.12$ 0.12$ (0.19)$ 0.33
Provider [Member]    
Revenue:    
Revenue from contract with customers$ 122,811$ 118,179$ 360,415$ 345,253
Cost of revenue:    
Total cost of revenue57,25261,606172,595180,566
Payer & Life Sciences [Member]    
Revenue:    
Revenue from contract with customers29,11126,48985,07774,273
Cost of revenue:    
Total cost of revenue$ 11,234$ 13,422$ 36,498$ 37,984

MDRX Balance Sheet

2022-09-30
CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Current assets:  
Cash and cash equivalents$ 492,597$ 132,517
Restricted cash1,3071,308
Accounts receivable, net of allowance of $12,868 and $13,360 as of September 30, 2022 and December 31, 2021, respectively169,029171,622
Contract assets, net of allowance of $564 and $576 as of September 30, 2022 and December 31, 2021, respectively65,45363,429
Prepaid expenses and other current assets74,38460,511
Assets held for sale8,000331,955
Total current assets attributable to discontinued operations810,770761,342
Fixed assets, net11,7139,819
Software development costs, net78,10374,688
Intangible assets, net145,255149,690
Goodwill523,927506,607
Deferred taxes, net60
Contract assets - long-term, net of allowance of $1,201 and $1,534 as of September 30, 2022 and December 31, 2021, respectively27,95728,174
Right-of-use assets - operating leases14,52018,324
Other assets78,40883,429
Long-term assets attributable to discontinued operations0793,156
Total assets1,690,6592,425,229
Current liabilities:  
Accounts payable12,6095,281
Accrued expenses82,91754,518
Accrued compensation and benefits33,85731,055
Deferred revenue98,930120,748
Current operating lease liabilities6,1666,133
Current liabilities attributable to discontinued operations18,612329,347
Total current liabilities attributable to discontinued operations253,091547,082
Long-term debt200,326350,062
Deferred revenue3,0601,839
Deferred taxes, net8,08216,625
Long-term operating lease liabilities12,31516,754
Other liabilities36,76233,823
Long-term liabilities attributable to discontinued operations050,906
Total liabilities513,6361,017,091
Commitments and contingencies
Stockholders’ equity:  
Preferred stock: $0.01 par value, 1,000 shares authorized, no shares issued and outstanding as of September 30, 2022 and December 31, 202100
Common stock: $0.01 par value, 349,000 shares authorized as of September 30, 2022 and December 31, 2021; 279,600 and 109,260 shares issued and outstanding as of September 30, 2022, respectively; 276,705 and 116,114 shares issued and outstanding as of December 31, 2021, respectively2,7942,766
Treasury stock: at cost, 170,340 and 160,591 shares as of September 30, 2022 and December 31, 2021, respectively(1,498,836)(1,321,805)
Additional paid-in capital1,923,5591,962,386
Retained earnings753,392767,556
Accumulated other comprehensive loss(3,886)(2,765)
Total stockholders’ equity1,177,0231,408,138
Total liabilities and stockholders’ equity$ 1,690,659$ 2,425,229
Richard J. Poulton
8000
Allscripts Healthcare Solutions, Inc., together with its subsidiaries, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions. The company operates through two segments, Hospitals and Large Physician Practices, and Veradigm. The Hospitals and Large Physician Practices segment provides integrated clinical and financial management solutions, which primarily include EHR-related software; and related installation, support and maintenance, outsourcing, private cloud hosting, and revenue cycle management services. The Veradigm segment offers payer and life sciences solutions, which are primarily targeted at payers, life sciences companies, and other healthcare stakeholders; and software applications for patient engagement and EHR software to single-specialty, and small and mid-sized physician practices, including related clinical, financial, administrative, and operational solutions. Its solutions enable clients to transition, analyze, and coordinate care, and enhance the healthcare delivery across the care community. The company serves physicians, hospitals, governments and militaries, health systems, health plans, life-sciences companies, retail clinics, surgery centers, retail pharmacies, pharmacy benefit managers, insurance companies, employer wellness clinics, consumers, lab companies, urgent care facilities, and venture capital firms, as well as post-acute organizations, such as home health and hospice agencies. Allscripts Healthcare Solutions, Inc. was founded in 1986 and is headquartered in Chicago, Illinois.